Genetically-Enhanced Mesenchymal stem cells (GEM)

DRUG/DEVICE
Allogeneic human Mesenchymal Stem Cells (MSCs) modified with gene transfer.
ROUTE OF ADMINISTRATION
Intravenous
THERAPEUTIC PLATFORM
NCE / Novel Biologics
CLINICAL TRIAL
TERRITORY
Canadian Study; United States license
STATUS
Phase 1
Genetically-Enhanced MSC (GEM) is a development-stage product not approved for sale in any jurisdiction.